Skip to main content
Christopher Pittenger, MD, Psychiatry, New Haven, CT

ChristopherJohnPittengerMD

Psychiatry New Haven, CT

Director, Yale OCD Research Clinic Assistant Professor of Psychiatry Yale University

Dr. Pittenger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Pittenger's full profile

Already have an account?

  • Office

    34 Park St
    # 3
    New Haven, CT 06519
    Phone+1 203-974-7560
    Fax+1 203-974-7662

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Psychiatry, 2003 - 2007
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 2003

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2005 - 2025
  • American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Distinct but Synergistic Roles for Histone Deacetylase in the Dorsal Striatum During Habit Formation  
    Christopher Pittenger, MD, Biological Psychiatry

Authored Content

  • Distinct but Synergistic Roles for Histone Deacetylase in the Dorsal Striatum During Habit FormationAugust 2018
  • Developing Image Sets for Inducing Obsessive-Compulsive Checking SymptomsApril 2018

Press Mentions

  • Youth Suicide Is on the Rise: Yale Aims to Save Lives
    Youth Suicide Is on the Rise: Yale Aims to Save LivesSeptember 11th, 2024
  • Yale Researchers Awarded $20.6M Grant for Wide-Ranging Study of Mental Illness
    Yale Researchers Awarded $20.6M Grant for Wide-Ranging Study of Mental IllnessAugust 29th, 2024
  • A Yale Doctor Is 'Very Encouraged' That a Psychedelic Drug May Combat Anxiety and Alcoholism
    A Yale Doctor Is 'Very Encouraged' That a Psychedelic Drug May Combat Anxiety and AlcoholismSeptember 15th, 2022
  • Join now to see all

Grant Support

  • 5-HT1B Receptor Function In OCDNational Institute Of Mental Health2011–2012
  • CREB And The Molecular Underpinnings Of Habit LearningNational Institute Of Mental Health2008–2012
  • Pathophysiologically Realistic Mouse Models Of Neuropsychiatric Disease: TouretteNational Institute Of Mental Health2010–2011
  • Targeting Glutamate In OCD: A Placebo-Controlled, Double-Blind Augmentation TrialNational Institute Of Mental Health2009–2011
  • CREB In Declarative And Non-Declarative Memory In MouseNational Institute Of Mental Health2001